By Drug Target Review2025-06-04T12:31:13
Scientists have used AI to design a molecule that disrupts a key protein interaction driving up to 70 percent of cancers - once thought impossible to drug.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2024-01-19T07:40:55
Sponsored by Euretos
2023-09-06T16:55:04
Sponsored by NanoTemper Technologies
2023-05-10T11:18:16
Sponsored by Revvity
Site powered by Webvision Cloud